Skip to content

Study · Animal study (in vivo) · mouse · 2015

1 result

Inconsistencies in the hypophagic action of intracerebroventricular insulin in mice.

Mc Allister E, Pacheco-Lopez G, Woods SC, Langhans W

Physiology & behavior3 Sept 2015Cited by 8 (Europe PMC)

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study1

1 result from studies that gave the peptide. No result from this study comes from people.

  1. 01AnimalAnimal study (in vivo)Efficacy outcome

    In mice that did not reduce food intake after higher doses of third-ventricle insulin, third-ventricle melanotan II (MT-II) did reduce food intake.

    In plain wordsIn mice that did not eat less after high-dose brain insulin, melanotan II still reduced their food intake.

    Outcome
    DecreaseFood intake after MT-II in mice not responding to insulin
    Study

    mousen: not reported in source

    Outcome group
    Appetite and food intake · Nervous system and cognition
    Studied dose
    Dose not stated · intracerebroventricular (third ventricle)As given in this study (mouse).

    Source sentences

    Summary
    Mice that did not reduce food intake in response to higher doses of i3vt insulin did so in response to i3vt infusion of the melanocortin receptor agonist melanotan-II (MT-II)

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    10 Oct 2026, 09:43 UTC

    Study results updated

  2. Version 1

    9 Oct 2026, 03:04 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.